Jump to content


Photo

Cost of Generic Imatinib just got higher!


  • Please log in to reply
102 replies to this topic

#1 Dom

Dom

    Advanced Member

  • Members
  • PipPipPip
  • 186 posts
  • LocationNew Jersey

Posted 26 October 2017 - 01:58 PM

Did anyone else notice that the cost of imatinib just got much higher.  My 100's are now $4,800 (compared to just $1,000 last month).  And the cost of the 400's will show a similar 400% jump.  All of which is reflected in my medicare costs.

 

I put a great deal of effort to (1) figure out the cost of my medicare part D, and (2) change my lifestyle to fit it.  Now everything goes kablooey.

 

How does this happen?  They were making a huge profit at the old cost, now it jumps up!  And I don't trust that this is the end of it.  I suspect we will be seeing prices of $12,000 again, just like the bad old days before it went generic.


Diagnosed in February 2014. Started Imatinib 400 in April.
2014:     3.18     0.91
2015:     0.22     0.16     0.04     0.55
2016:     0.71     0.66

(Started Imatinib 600 in April 2016)
2016:     0.42     0.13     0.45
2017:     0.17     0.06     0.10     0.06     0.34


#2 AllTheseYears

AllTheseYears

    Advanced Member

  • Members
  • PipPipPip
  • 73 posts
  • LocationNorth Carolina

Posted 26 October 2017 - 02:34 PM

Dom,

 

This news regarding Gleevec cost I find very distressing.  I've been taking Gleevec since it was introduced (hence my User Name) and have felt exploited since the first price hike ages ago. The price hikes keep on coming, even with generic obviously.  The huge profits began early on with the justification from Novartis being that it offers a product that has high demand (since it keeps people from dying) and so justifies rising profits. It's just business, only in America of course.

 

I'm retired and now on Medicare and, like you, I've worked my finances around the huge Part D copays to obtain my treatment. This news truly is distressing.  (Before I was on Medicare, I also lived in a state without oral parity so my copays on regular insurance were high.) I'm fed up with being exploited because I have this inexplicable wish to live and not end up homeless.  I've written letters, made phone calls, talked about this ad nauseam without positive change happening.  Profits are fine; profiteering is not. Any suggestions as to what we survivors can now do?



#3 Antilogical

Antilogical

    Advanced Member

  • Members
  • PipPipPip
  • 284 posts
  • LocationPittsburgh, PA

Posted 26 October 2017 - 02:47 PM

I tried investigating imatinib costs for 2018 before making a final decision on a Medicare plan.  The customer service agent spent hours (no lie!) trying to get a cost for me, as well as pin down which generic company would be supplying the drug.  First, she gave me a cost that was 30% higher than this year's cost, but later she found out that the higher cost was the list price for customers without insurance.  The insurance plan's cost for next year is about the same as for this year.  My co-pays are based off of the plan's cost, and they were the same this month as they were last month.

 

I hope I don't get the same ugly news when I reorder in a couple of weeks....


Dx: Sudden severe anemia detected 07/2011, followed by WBC spike. CML Dx 02/2012.

Rx: 03/2012-Gleevec400.  Reduced 02/2013 to Gleevec300 due to side effects (low blood counts).

Response: PCR-Und within 7 mo. on G400. Maintained MMR4-MMR4.5 on G300. PCR-Und since 02/2016.


#4 Buzzm1

Buzzm1

    Advanced Member

  • Members
  • PipPipPip
  • 972 posts
  • LocationSilicon Valley

Posted 26 October 2017 - 03:04 PM

I tried investigating imatinib costs for 2018 before making a final decision on a Medicare plan.  The customer service agent spent hours (no lie!) trying to get a cost for me, as well as pin down which generic company would be supplying the drug.  First, she gave me a cost that was 30% higher than this year's cost, but later she found out that the higher cost was the list price for customers without insurance.  The insurance plan's cost for next year is about the same as for this year.  My co-pays are based off of the plan's cost, and they were the same this month as they were last month.

 

I hope I don't get the same ugly news when I reorder in a couple of weeks....

Antilogical, pardon me if I am incorrect, but aren't you already paying considerably higher prices for your generic Imatinib than Dom and shweflen.  They both have Express Scripts through Walmart and generic Imatinib had been priced at:

 

Dom:  $1914.17 for 30 X 400mg + $1062.90 for 60 X 100mg
shweflen $1593.82 for 90 X 100mg

 

Just trying to keep things in perspective.


For the benefit of yourself and others please add your CML history into your Signature

 

02/2010 Gleevec 400mg

2011 Two weakly positives, PCRU, weakly positive

2012 PCRU, PCRU, PCRU, PCRU

2013 PCRU, PCRU, PCRU, weakly positive

2014 PCRU, PCRU, PCRU, PCRU (12/07 began dose reduction w/each continuing PCRU)

2015 300, 250, 200, 150

2016 100, 50/100, 100, 10/17 TFR

2017 01/17 TFR, 04/18 TFR, 07/18 TFR 0.0012, 08/29 TFR 0.001, 10/17 TFR 0.000

2018 01/16 TFR 0.0004 ... next quarterly PCR 04/17

 

At the earliest opportunity, and whenever possible, lower your TKI dosage; TKIs are toxic drugs and the less we take longterm the better off we are going to be ... this is especially true for older adults.  

 

In hindsight I should have started my dosage reduction two years earlier; it might have helped minimize some of the longterm cumulative toxic effects of TKIs that I am beset with.  

 

longterm side-effects Peripheral Artery Disease - legs (it's a bitch); continuing shoulder problems, right elbow inflammation.   GFR and creatinine vastly improved after stopping Gleevec.

 

Cumulative Gleevec dosage estimated at 830 grams

 

Taking Gleevec 400mg an hour after my largest meal of the day helped eliminate the nausea that Gleevec is notorious for.  

 

Trey's CML BlogStopping - The OddsStop Studies - Discussion Forum Cessation Study

Big PhRMA - Medicare Status - Social Security Status - Deficit/Debt


#5 Buzzm1

Buzzm1

    Advanced Member

  • Members
  • PipPipPip
  • 972 posts
  • LocationSilicon Valley

Posted 26 October 2017 - 03:45 PM

If anything, for those that can, this is another argument for further dosage reduction ... consider it a forced dosage reduction.

With generics, having to pay the full $5,000 (2018) out-of-pocket before reaching catastrophic phase is a real bummer.


For the benefit of yourself and others please add your CML history into your Signature

 

02/2010 Gleevec 400mg

2011 Two weakly positives, PCRU, weakly positive

2012 PCRU, PCRU, PCRU, PCRU

2013 PCRU, PCRU, PCRU, weakly positive

2014 PCRU, PCRU, PCRU, PCRU (12/07 began dose reduction w/each continuing PCRU)

2015 300, 250, 200, 150

2016 100, 50/100, 100, 10/17 TFR

2017 01/17 TFR, 04/18 TFR, 07/18 TFR 0.0012, 08/29 TFR 0.001, 10/17 TFR 0.000

2018 01/16 TFR 0.0004 ... next quarterly PCR 04/17

 

At the earliest opportunity, and whenever possible, lower your TKI dosage; TKIs are toxic drugs and the less we take longterm the better off we are going to be ... this is especially true for older adults.  

 

In hindsight I should have started my dosage reduction two years earlier; it might have helped minimize some of the longterm cumulative toxic effects of TKIs that I am beset with.  

 

longterm side-effects Peripheral Artery Disease - legs (it's a bitch); continuing shoulder problems, right elbow inflammation.   GFR and creatinine vastly improved after stopping Gleevec.

 

Cumulative Gleevec dosage estimated at 830 grams

 

Taking Gleevec 400mg an hour after my largest meal of the day helped eliminate the nausea that Gleevec is notorious for.  

 

Trey's CML BlogStopping - The OddsStop Studies - Discussion Forum Cessation Study

Big PhRMA - Medicare Status - Social Security Status - Deficit/Debt


#6 Dom

Dom

    Advanced Member

  • Members
  • PipPipPip
  • 186 posts
  • LocationNew Jersey

Posted 26 October 2017 - 03:55 PM

"Any suggestions as to what we survivors can now do?"

 

This piece increase is coming from the manufacturer, not from medicare.  As far as I know, the production of generic imatinib is restricted to one company.  Can anyone confirm this?  If it's true, that's the problem -- no competition.  And like I said, it means the increases won't stop.  It's going to get worse.

 

"this is another argument for further dosage reduction"

 

My oncololgist is not even considering dosage reduction.  I actually increased from 400 to 600.  And I can't use the other tki's since I have heart problems.


Diagnosed in February 2014. Started Imatinib 400 in April.
2014:     3.18     0.91
2015:     0.22     0.16     0.04     0.55
2016:     0.71     0.66

(Started Imatinib 600 in April 2016)
2016:     0.42     0.13     0.45
2017:     0.17     0.06     0.10     0.06     0.34


#7 Buzzm1

Buzzm1

    Advanced Member

  • Members
  • PipPipPip
  • 972 posts
  • LocationSilicon Valley

Posted 26 October 2017 - 04:06 PM

As far as I know, the production of generic imatinib is restricted to one company.  Can anyone confirm this?  If it's true, that's the problem -- no competition.  

Dom, there are currently three U.S. manufacturers of generic Imatinib, Sun, Apotex, and Teva.


For the benefit of yourself and others please add your CML history into your Signature

 

02/2010 Gleevec 400mg

2011 Two weakly positives, PCRU, weakly positive

2012 PCRU, PCRU, PCRU, PCRU

2013 PCRU, PCRU, PCRU, weakly positive

2014 PCRU, PCRU, PCRU, PCRU (12/07 began dose reduction w/each continuing PCRU)

2015 300, 250, 200, 150

2016 100, 50/100, 100, 10/17 TFR

2017 01/17 TFR, 04/18 TFR, 07/18 TFR 0.0012, 08/29 TFR 0.001, 10/17 TFR 0.000

2018 01/16 TFR 0.0004 ... next quarterly PCR 04/17

 

At the earliest opportunity, and whenever possible, lower your TKI dosage; TKIs are toxic drugs and the less we take longterm the better off we are going to be ... this is especially true for older adults.  

 

In hindsight I should have started my dosage reduction two years earlier; it might have helped minimize some of the longterm cumulative toxic effects of TKIs that I am beset with.  

 

longterm side-effects Peripheral Artery Disease - legs (it's a bitch); continuing shoulder problems, right elbow inflammation.   GFR and creatinine vastly improved after stopping Gleevec.

 

Cumulative Gleevec dosage estimated at 830 grams

 

Taking Gleevec 400mg an hour after my largest meal of the day helped eliminate the nausea that Gleevec is notorious for.  

 

Trey's CML BlogStopping - The OddsStop Studies - Discussion Forum Cessation Study

Big PhRMA - Medicare Status - Social Security Status - Deficit/Debt


#8 Dom

Dom

    Advanced Member

  • Members
  • PipPipPip
  • 186 posts
  • LocationNew Jersey

Posted 26 October 2017 - 06:56 PM

Thanks Buzz. Is there a difference in prices?

Diagnosed in February 2014. Started Imatinib 400 in April.
2014:     3.18     0.91
2015:     0.22     0.16     0.04     0.55
2016:     0.71     0.66

(Started Imatinib 600 in April 2016)
2016:     0.42     0.13     0.45
2017:     0.17     0.06     0.10     0.06     0.34


#9 Buzzm1

Buzzm1

    Advanced Member

  • Members
  • PipPipPip
  • 972 posts
  • LocationSilicon Valley

Posted 26 October 2017 - 07:20 PM

Thanks Buzz. Is there a difference in prices?

That's the $64 million dollar question?  We don't yet know the answer..

From everything that has been said, especially if the price using Express Scripts and Walmart goes up, it would appear that there is collusion going on.  Then again, Kaiser's 2018 Formulary has generic Imatinib scheduled as a Tier 2 drug, so perhaps there are other exceptions.


For the benefit of yourself and others please add your CML history into your Signature

 

02/2010 Gleevec 400mg

2011 Two weakly positives, PCRU, weakly positive

2012 PCRU, PCRU, PCRU, PCRU

2013 PCRU, PCRU, PCRU, weakly positive

2014 PCRU, PCRU, PCRU, PCRU (12/07 began dose reduction w/each continuing PCRU)

2015 300, 250, 200, 150

2016 100, 50/100, 100, 10/17 TFR

2017 01/17 TFR, 04/18 TFR, 07/18 TFR 0.0012, 08/29 TFR 0.001, 10/17 TFR 0.000

2018 01/16 TFR 0.0004 ... next quarterly PCR 04/17

 

At the earliest opportunity, and whenever possible, lower your TKI dosage; TKIs are toxic drugs and the less we take longterm the better off we are going to be ... this is especially true for older adults.  

 

In hindsight I should have started my dosage reduction two years earlier; it might have helped minimize some of the longterm cumulative toxic effects of TKIs that I am beset with.  

 

longterm side-effects Peripheral Artery Disease - legs (it's a bitch); continuing shoulder problems, right elbow inflammation.   GFR and creatinine vastly improved after stopping Gleevec.

 

Cumulative Gleevec dosage estimated at 830 grams

 

Taking Gleevec 400mg an hour after my largest meal of the day helped eliminate the nausea that Gleevec is notorious for.  

 

Trey's CML BlogStopping - The OddsStop Studies - Discussion Forum Cessation Study

Big PhRMA - Medicare Status - Social Security Status - Deficit/Debt


#10 M.A.

M.A.

    Advanced Member

  • Members
  • PipPipPip
  • 55 posts
  • LocationAustralia

Posted 26 October 2017 - 11:27 PM

I am very sorry to hear about all that you in the US have to go through in terms of financing your pharmaceuticals. The system seems cruel for many and also incredibly complex.

 

In Australia we pay $38.80 per month for our TKI regardless of what dosage we are on due to the Pharmaceutical Benefits Scheme (PBS) and for people on welfare it is $6.30.

 

We also have a PBS Safety Net:
 
$1,494.90 for general patients, or
$378 for concession card holders
 
When you reach the PBS Safety Net threshold your medication for the remainder of the year is:
 
up to $6.30 for general patients
free for concession card holders
 
I hope we can keep this current system of ours in place.
 
Not mentioning it to gloat. Far from it. I realise it's complex and the US has a different political and bureaucratic ecosystem to Australia.
 
Just mentioning it to show how another country does it.
 
My heartfelt good wishes to all of you and good luck in getting this latest hike in imatinib price reduced!

CML diagnosed April 2016

Type One Diabetes diagnosed April 1980 (age 12)

 

BCR-ABL (IS)

46.77  April 2016

3.568  July 2016  

0.076  Oct 2016

0.016  Feb 2017

0.0079  April 2017

0.014  July 2017

0.019  Sept 2017

0.011  Nov 2017

0.019  Jan 2018

 

Sprycel

100mg April 29 - September 22

75mg  September 23 - October 28

50mg October 29 2016 to present


#11 Buzzm1

Buzzm1

    Advanced Member

  • Members
  • PipPipPip
  • 972 posts
  • LocationSilicon Valley

Posted 27 October 2017 - 12:43 AM

Thank you M.A. ... that's great information ...


For the benefit of yourself and others please add your CML history into your Signature

 

02/2010 Gleevec 400mg

2011 Two weakly positives, PCRU, weakly positive

2012 PCRU, PCRU, PCRU, PCRU

2013 PCRU, PCRU, PCRU, weakly positive

2014 PCRU, PCRU, PCRU, PCRU (12/07 began dose reduction w/each continuing PCRU)

2015 300, 250, 200, 150

2016 100, 50/100, 100, 10/17 TFR

2017 01/17 TFR, 04/18 TFR, 07/18 TFR 0.0012, 08/29 TFR 0.001, 10/17 TFR 0.000

2018 01/16 TFR 0.0004 ... next quarterly PCR 04/17

 

At the earliest opportunity, and whenever possible, lower your TKI dosage; TKIs are toxic drugs and the less we take longterm the better off we are going to be ... this is especially true for older adults.  

 

In hindsight I should have started my dosage reduction two years earlier; it might have helped minimize some of the longterm cumulative toxic effects of TKIs that I am beset with.  

 

longterm side-effects Peripheral Artery Disease - legs (it's a bitch); continuing shoulder problems, right elbow inflammation.   GFR and creatinine vastly improved after stopping Gleevec.

 

Cumulative Gleevec dosage estimated at 830 grams

 

Taking Gleevec 400mg an hour after my largest meal of the day helped eliminate the nausea that Gleevec is notorious for.  

 

Trey's CML BlogStopping - The OddsStop Studies - Discussion Forum Cessation Study

Big PhRMA - Medicare Status - Social Security Status - Deficit/Debt


#12 chriskuo

chriskuo

    Advanced Member

  • Members
  • PipPipPip
  • 367 posts

Posted 27 October 2017 - 01:53 AM

The Australian government negotiates the drug prices with the manufacturers.  The US Congress forbids Medicare from negotiating drug prices so the manufacturers have little to no incentive to control drug prices.  Under commercial plans for under-65s, the insurers/sponsors  can negotiate drug prices but they are never disclosed.  Drug companies can offer copay assistance to the needy to make sure that they continue to buy their TKIs at inflated prices.  To the extent discounts are negotiated, they are pocketed by the insurers/sponsors.



#13 AllTheseYears

AllTheseYears

    Advanced Member

  • Members
  • PipPipPip
  • 73 posts
  • LocationNorth Carolina

Posted 27 October 2017 - 07:32 AM

Of course we know the rising price of Gleevec comes from the manufacturer and not Medicare and no, competition is not the problem  In the U.S., Medicare does not negotiate drug prices.  Medicaid, Veterans Affairs and private insurance companies do negotiate drug prices but not our Medicare program. And, our congress will not cap rising drug prices, even when the prices rise only to expand big profits when R and D costs are already recovered.   Hence when we begin Medicare, as I did years ago, for most of us our copays become much higher than when we were on private insurance, and for me, my deduction also became much higher than when I was on private insurance.  Both copay and deductions vary with individual insurance companies' Part D plans.  I am with Humana and my monthly copay plus rising deductible plus the expensive "donut hole" that must be bridged, seem excessively high. My Gleevec out-of-pocket cost is just south of $11,000 per year.  I suspect other Part D plans are better regarding out-of-pocket and I was asking others for information about their Part D plans.  I might switch, since I face this financial burden for the rest of my life with CML.  Suggestions welcome.

 

What can we do about high Gleevec prices, including generic, I asked?    So far, I can think of only two things: One, continue to fight the seven state legislatures that refuse oral drug parity in their states (LLS is active in this effort on behalf of  pre-Medicare survivors); and, two, keep ragging congressional reps who are in Big Pharma's pocket by telling them our stories. If they don't listen and act, vote them out. The people representing us in government bear most of the responsibility for the profiteering of drug manufacturers. Why wouldn't Big Pharma make all the money they legally can on the backs of Americans who need their drugs to live?

 

To quote the now-popular Alexander Hamilton: Why has government been instituted at all? Because the passions of man will not conform to the dictates of reason and justice without restraint.  ...Big Pharma understandably wants to make as much money as possible, but I think its passion of greed needs to be restrained.



#14 Dom

Dom

    Advanced Member

  • Members
  • PipPipPip
  • 186 posts
  • LocationNew Jersey

Posted 27 October 2017 - 03:47 PM

I just went back to Medicare.Gov and got some interesting information.  My current  plan (Express Scripts at Walmart) will be $18,000 for the year.  I was expecting $6,500, given the old price of Imatinib.  Now it seems my best bet is Cigna HealthSpring RX Secure-Extra (PDP) using their mail order service (the mail order is a definite plus).  This comes to $8,500 for the year. 

 

Does anyone have any good or bad things to say about Cigna Part D?  I notice it has only 2 of 5 stars, but it doesn't explain the low rating.


Diagnosed in February 2014. Started Imatinib 400 in April.
2014:     3.18     0.91
2015:     0.22     0.16     0.04     0.55
2016:     0.71     0.66

(Started Imatinib 600 in April 2016)
2016:     0.42     0.13     0.45
2017:     0.17     0.06     0.10     0.06     0.34


#15 ROMO

ROMO

    Advanced Member

  • Members
  • PipPipPip
  • 76 posts

Posted 27 October 2017 - 04:28 PM

There are three companies in the US that make generic Gleevec.
Sun, Teva, and Apotex. I read this on Bloomberg.
 
ill-goes-generic-yet-patients-costs-stay-high
 
It is interesting to note that most manufacture of generic drugs are a 
subsidiary of the major drug companies. I have not researched these
companies pedigree. I don't have the Lawyers, Guns and Money. (Zevon)
 
The FDA has applications pending for other companies to make generic
Gleevec. When asked about the holdup the FDA had no comment.
 
The hold up for a price drop has nothing to do with Democrats or
Republicans, and every thing to do with the machine.
 
The high price benefits all the people at the top, and this will be a slow
decline until other TKI's go generic. There is some talk about government
being able to negotiate discounts, it's only talk. A politicians greatest gift.
 
Romo

DX August 2016. WBC ~160K
PH+ Cells 36%
No Spleen enlargement
No Symptoms. Other counts ~Normal
BCR-ABL p210 (Detected)
BCR-ABL p190 (Not Detected)
 
Sprycel 100mg.
PCR   02/01/2017    0.146 IS
PCR   08/07/2017    0.022 IS
Next PCR:           12/XX/2017
 

#16 Lori's okay

Lori's okay

    Member

  • Members
  • PipPip
  • 21 posts
  • LocationWashington DC area

Posted 27 October 2017 - 07:56 PM

I have been supremely grateful for good private insurance through my husband's employer and felt guilty knowing how unfair this system is. (we are just a couple of years from retirement and I've appreciated learning from you what lies ahead.) 

 

Novartis even offered me a copay assist card.   What I do not understand and seems outrageously unfair is that they offer these copay assist cards only for private insurance, specifically not for Medicare or Medicaid.  Is that because the company makes so much money off of the private insurance sales and want that to continue?  Are there government regulations that are preventing them from assisting those on Medicare?

 

My soapbox for a long time has been to liken drug prices for life threatening illnesses to the conditions where we outlaw price gouging in emergencies and natural disasters.  This seems like a nearly perfect analogy.  


DX 09-2011 PCR 8.08 not IS WBC 17 , Began Tasigna 600mg  

in 2012 Tasigna 450mg/day ,in 2013-2017 Tasigna 300mg/day

DATE/PCR

09-11/ 8.08 not IS

03-12/ 0.054 not IS

06-12/ 0.035 not IS

09-12/ PCRU, 01-13/ PCRU

4-13/ 0.042 IS

7-13/ 0.014 IS

11-13/ PCRU, 04-14/ PCRU

8-14/ 0.006 IS

PCRU: 12-14/ 05-15/ 10-15/ 02-16/ 

09-16/ 02-17/ 09-17/ 

10-17 tapered off 

11-3-17 Stopped Tasigna

1-15-18 still PCRU

 


#17 chriskuo

chriskuo

    Advanced Member

  • Members
  • PipPipPip
  • 367 posts

Posted 28 October 2017 - 01:03 AM

Assistance to Medicare recipients for drugs has to come from charities. Some drug companies push money
through charities that ultimately ends up with needy people but there can't be a direct linkage from the drug company

to the Medicare patient. Medicare cannot negotiate drug prices but they have this rule in place because drug companies
could recoup the copay assistance by raising the drug price and sticking Medicare with higher prices (particularly in the
catastrophic phase (which is where TKI patients quickly end up).

#18 DJ5627

DJ5627

    New Member

  • Members
  • Pip
  • 3 posts

Posted 28 October 2017 - 08:39 PM

Rant ahead:

 

Hello, I just had to add to the discussion.  Due to my dad having been retired military, my mother has Tricare and she pays only a few dollars, relatively speaking, for her Tasigna. 

I, on the other hand, am not fortunate enough to have Tricare.  Or Medicare.  Or a hefty income or savings.  If I get leukemia, basically I die.  Unless it's covered by some charity drug program, but really that should never have to happen at all.

 

Retail is about 90K a year. 

 

How is that not just flat out illegal?  These are wonderful medicines, and we are incredibly grateful for them.  

 

However, the system is just plain criminal that so much money can be made off the backs of sick people.  Obscene.  Remember Pharma Bro? Obscene profits draw sociopaths like moths to a flame.  

 

Many politicians are wealthy to start with, and they aren't in iminent danger of losing their health insurance.  They have no idea what it means to struggle to pay a bill, or to choose between medicine and food, or to end up with no retirement because some greedy drug company demanded a ransom for your life. Some of them try to understand, and to do some good, but they are blocked politically and will continue to be until the American people stand up and hold accountable the people who are standing in the way.   

 

I've never understood why we can't put partisanship aside and simply get about solving problems.  There are working models all over the world that have been tested and proven.   Surely one of them could inspire a model for ours.

 

/Rant 



#19 shweflen

shweflen

    Advanced Member

  • Members
  • PipPipPip
  • 51 posts
  • LocationAnderson, IN

Posted 29 October 2017 - 03:40 PM

I just went back to Medicare.Gov and got some interesting information.  My current  plan (Express Scripts at Walmart) will be $18,000 for the year.  I was expecting $6,500, given the old price of Imatinib.  Now it seems my best bet is Cigna HealthSpring RX Secure-Extra (PDP) using their mail order service (the mail order is a definite plus).  This comes to $8,500 for the year. 

 

Does anyone have any good or bad things to say about Cigna Part D?  I notice it has only 2 of 5 stars, but it doesn't explain the low rating.

I checked the same thing.  I got on Cigna's website and, according to their formulary, 100 mg imatinib is quantity limited to 60 pills per month.  Since I take 300 mg per day that wouldn't work for me.  I called Cigna and they told me I could get a waiver to the quantity limit but the only way to know if they will grant the waiver is to enroll in the plan and then ask.

 

Antilogical, pardon me if I am incorrect, but aren't you already paying considerably higher prices for your generic Imatinib than Dom and shweflen.  They both have Express Scripts through Walmart and generic Imatinib had been priced at:

 

Dom:  $1914.17 for 30 X 400mg + $1062.90 for 60 X 100mg
shweflen $1593.82 for 90 X 100mg

 

Just trying to keep things in perspective.

The last two months, WalMart has increased the cost of imatinib to me from 5% of $1593.82 to 5% of $5044.87 because they had to buy from Sun instead of Apotek


10/20/2016 BCR-ABL:ABL = 81.622

01/11/2017 BCR-ABL:ABL =   8.028

04/12/2017 BCR-ABL:ABL =   0.157

07/07/2017 BCR-ABL:ABL =   0.000

10/04/2017 BCR-ABL:ABL =   0.041

11/28/2017 BCR-ABL:ABL =   0.000

 

 


#20 Dom

Dom

    Advanced Member

  • Members
  • PipPipPip
  • 186 posts
  • LocationNew Jersey

Posted 29 October 2017 - 06:00 PM

Shweflen, imatinib 400 mg is on the formulary for 30 per month, so it seems strange that they won't allow 300 mg. I bet with the oncologist's authorization, you can get it. My one remaining concern is the rating. It's only 2 out of 5. Express scripts is 4 out of 5.

I'm still waiting for someone around here with real experience with Cigna to give me positive or negative recommendations.

Diagnosed in February 2014. Started Imatinib 400 in April.
2014:     3.18     0.91
2015:     0.22     0.16     0.04     0.55
2016:     0.71     0.66

(Started Imatinib 600 in April 2016)
2016:     0.42     0.13     0.45
2017:     0.17     0.06     0.10     0.06     0.34





1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users